Streetbeat News

Partnerships

MRNA

MYNZ

PFE

Mainz Biomed NV (NASDAQ:MYNZ) announced it will be launching its flagship product, ColoAlert®, a colorectal cancer test, in Romania through a strategic partnership with Bioclinica. The potential market for ColoAlert® in Romania is substantial, reaching 9.2 million tests per year. Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA) are also noted for their progress in cancer treatments.

Portfolio Pulse from Upwallstreet

October 04, 2023 | 4:10 pm

BUD

CMCSA

CPB

LOW

PFE

The romance between NFL star Travis Kelce and musician Taylor Swift has increased Kelce's popularity, which could benefit his brand partners. A Morning Consult poll shows that awareness and favorability for Kelce have increased over the last year, partly due to his association with Swift. This could be positive for media companies like Comcast Corporation, which broadcasted a game featuring Kelce. Other potential winners include sportsbooks, media companies, and brands that Kelce endorses, such as Experian, State Farm Insurance, Pfizer, Campbell Soup Company, Lowe’s Companies, DirecTV, and Anheuser-Busch InBev.

Portfolio Pulse from Chris Katje

October 04, 2023 | 3:40 pm

ABBV

AbbVie, the Broad Institute of MIT and Harvard, and Calico Life Sciences have announced the publication of preclinical data for ABBV-CLS-484, a potential first-in-class, orally bioavailable, PTPN2/N1 phosphatase inhibitor that enhances anti-tumor immunity. The findings support the development of ABBV-CLS-484 as a promising new strategy for cancer immunotherapy. ABBV-CLS-484 is currently in an AbbVie and Calico-led Phase 1 clinical trial in solid tumors.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 3:10 pm

VVOS

Vivos Therapeutics Inc (NASDAQ:VVOS) has announced two strategic agreements with Ormco and On Demand Orthodontist to provide Spark Clear Aligners to its national network of providers. This is expected to create additional revenue opportunities and expand Vivos' product line. The collaboration will also facilitate pricing discounts for Vivos' providers and joint marketing and sales support. The company expects faster treatment times and improved clinical outcomes for patients using Vivos CARE devices with Spark Aligners.

Portfolio Pulse from Vandana Singh

October 04, 2023 | 2:36 pm

ETR

HWC

Hancock Whitney (HWC) and Entergy (ETR) have announced a strategic relationship to support entrepreneurial and small business success for diverse and local business owners. The initiative combines Hancock Whitney's Small Business Matters program and Entergy's supplier diversity and inclusion team to enhance financial resilience and business development opportunities for diverse and local businesses.

Portfolio Pulse from Happy Mohamed

October 04, 2023 | 2:33 pm

KBR

KBR Inc has signed a Memorandum of Understanding (MoU) with SolydEra to offer an integrated solution for producing lower cost clean ammonia using renewable energy. KBR will integrate SolydEra's Solid Oxide Electrolysis (SOE) technology into its K-GreeN process to deliver highly efficient green ammonia capacity worldwide. The partnership is expected to deliver competitive levelized costs of carbon-neutral ammonia to accelerate the energy transition globally.

Portfolio Pulse from Shivani Kumaresan

October 04, 2023 | 2:04 pm

AMD

SSNLF

Samsung is rumored to be terminating its partnership with AMD for GPU development, as it plans to develop its own custom smartphone GPU. The underwhelming performance of the Xclipse 920 GPU, a part of the Exynos 2200, is cited as a possible reason for this decision. Samsung aims to increase competitiveness in various sectors, including automotive and AI, with an in-house GPU.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:52 pm

PLTR

Palantir Technologies Inc. (PLTR) is expanding its collaboration with PwC to combine its AI capabilities. The company has chosen the U.K. as its European headquarters for AI research and development. Palantir is also reportedly poised to secure a significant contract with the U.K.'s National Health Service (NHS), valued at approximately £480 million ($579 million). However, the financial impact of the NHS contract might not significantly influence Palantir's immediate financial results.

Portfolio Pulse from Nabaparna Bhattacharya

October 04, 2023 | 1:33 pm

BCTX

BriaCell has partnered with New York Cancer & Blood Specialists (NYCBS) for a pivotal Phase 3 study of Bria-IMT in advanced breast cancer.

Portfolio Pulse from Bill Haddad

October 04, 2023 | 1:16 pm

SNX

TD SYNNEX (NYSE:SNX) will be the exclusive North American distributor for the new suite of business products announced by Meta. The products, integrated with the Metaverse, aim to reshape business operations. The new Meta Quest 3 headset and the Meta for Work product portfolio will be launched globally in October. These products will first be available in the U.S. and Canada, followed by rollouts across Europe.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:12 pm